ADMA - ADMAバイオロジックス (ADMA Biologics Inc)

ADMAのニュース

   ADMA Biologics'' Q4 Top-Line Surpass Estimates, Concludes $175M Debt Refinancing  2022/03/25 12:34:34 Benzinga
ADMA Biologics Inc (NASDAQ: ADMA ) closed a debt refinancing with Hayfin Capital Management of $150 million, and up to an additional $25 million tied to specific revenue targets during 2022. The first tranche of the newly issued loan from Hayfin was fully drawn and used to completely repay the obligations under the Perceptive Advisors senior secured notes. As previously disclosed, ADMA has engaged Morgan Stanley (NYSE: MS ) as an advisor … Full story available on Benzinga.com
   ADMA Biologics gets FDA approval to extend shelf life of Asceniv, Bivigam  2022/03/25 11:28:30 Seeking Alpha
ADMA Biologics (ADMA) said the U.S. Food and Drug Administration ((FDA)) approved to extend the expiration dating to 36 months from 24 months for its Asceniv and Bivigam immune…
   ADMA Biologics up in after-hours trading following quarterly top and bottom line beats  2022/03/24 21:06:33 Seeking Alpha
Shares of ADMA Biologics (ADMA) are up 2% in after-hours trading after the company''s Q4 2021 results beat on both the top and bottom lines.
   ADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61M  2022/03/24 20:19:11 Seeking Alpha
ADMA Biologics press release (ADMA): Q4 GAAP EPS of -$0.09 beats by $0.01.Revenue of $26.38M (+89.0% Y/Y) beats by $4.61M.Shares +3.3%.
   ADMA Biologics Q4 2021 Earnings Preview  2022/03/23 21:35:02 Seeking Alpha
ADMA Biologics (ADMA) is scheduled to announce Q4 earnings results on Thursday, March 24th, after market close.The consensus EPS Estimate is -$0.09 (+55.0% Y/Y) and the consensus…
   ADMA Biologics (NASDAQ:ADMA) Coverage Initiated by Analysts at Cantor Fitzgerald  2021/11/09 10:22:41 Dakota Financial News
Cantor Fitzgerald initiated coverage on shares of ADMA Biologics (NASDAQ:ADMA) in a report released on Monday morning, The Fly reports. The firm issued an overweight rating on the biotechnology companys stock. A number of other brokerages also recently weighed in on ADMA. Zacks Investment Research upgraded shares of ADMA Biologics from a hold rating to []
   ADMA Biologics (NASDAQ:ADMA) Receives New Coverage from Analysts at Cantor Fitzgerald  2021/11/09 10:22:41 Transcript Daily
Cantor Fitzgerald started coverage on shares of ADMA Biologics (NASDAQ:ADMA) in a research note issued to investors on Monday morning, The Fly reports. The brokerage issued an overweight rating on the biotechnology companys stock. Several other equities research analysts have also issued reports on the company. Raymond James reduced their price target on ADMA Biologics []
   Analysts Predict A Surge In ADMA Biologics Inc. (NASDAQ: ADMA)?  2021/11/05 11:00:00 Stocks Register
ADMA Biologics Inc. (NASDAQ:ADMA) shares, rose in value on Thursday, 11/04/21, with the stock price down by -5.37% to the previous days close as strong demand from buyers drove the stock to $1.41. Actively observing the price movement in the last trading, the stock closed the session at $1.49, falling within a range of $1.37 Analysts Predict A Surge In ADMA Biologics Inc. (NASDAQ: ADMA)? Read More »
   ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021  2021/11/03 11:00:00 Intrado Digital Media
Conference Call Scheduled for November 10, 2021 at 4:30 p.m. ET Conference Call Scheduled for November 10, 2021 at 4:30 p.m. ET
   Why ADMA Biologics Inc. (NASDAQ: ADMA) Stock Should Not Be Taken For Granted By Investors In 2021  2021/11/01 14:30:00 Marketing Sentinel
In the last trading session, 3.14 million shares of the ADMA Biologics Inc. (NASDAQ:ADMA) were traded, and its beta was 1.27. Most recently the companys share price was $1.29, and it changed around -$0.05 or -3.73% from the last close, which brings the market valuation of the company to $177.90M. ADMA currently trades at a Why ADMA Biologics Inc. (NASDAQ: ADMA) Stock Should Not Be Taken For Granted By Investors In 2021 Read More »
   ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021  2021/10/01 11:00:00 Intrado Digital Media
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (ADMA or the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced an exclusive educational event at IDWeek 2021 on respiratory viral infections, presented by nationally recognized clinical experts Dr. Michael Ison from Northwestern University and Dr. Jolan Walter from the University of South Florida and Johns Hopkins All Childrens Hospital. Two leading experts in the management of respiratory syncytial virus (RSV) and other respiratory viruses in immunocompromised patients will discuss todays key clinical challenges and emerging treatment strategies. A novel intravenous immunoglobulin (IVIG) product with a unique composition will be introduced, including patient cases.
   Is ADMA Biologics Inc (ADMA) A Good Stock To Buy?  2021/09/29 18:27:49 Insider Monkey
   Dangling stocks: ADMA Biologics, Inc. (NASDAQ:ADMA -2.34%), Check-Cap Ltd. (NASDAQ:CHEK -1.10%)  2021/09/26 23:26:49 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Dangling stocks: ADMA Biologics, Inc. (NASDAQ:ADMA -2.34%), Check-Cap Ltd. (NASDAQ:CHEK -1.10%) appeared first on Stocks Equity .
   Tiling stocks: Advaxis, Inc. (NASDAQ:ADXS -0.61%), ADMA Biologics, Inc. (NASDAQ:ADMA 2.79%)  2021/09/24 00:01:28 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Tiling stocks: Advaxis, Inc. (NASDAQ:ADXS -0.61%), ADMA Biologics, Inc. (NASDAQ:ADMA 2.79%) appeared first on Stocks Equity .
   ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference  2021/09/23 11:00:00 Intrado Digital Media
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 23, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that Adam Grossman, President and Chief Executive Officer, will participate in a virtual fireside chat at the Cantor Healthcare Conference on September 30, 2021, at 9:20 a.m. ET.

calendar